6-bromo-N-methyl-2-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-imidazo[4,5-b]pyridin-7-amine
C20H24BrN5O2 — CID 70689445
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-bromo-N-methyl-2-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-imidazo[4,5-b]pyridin-7-amine
6-bromo-N-methyl-2-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-imidazo[4,5-b]pyridin-7-amine (PubChem CID 70689445) has the molecular formula C20H24BrN5O2 and a molecular weight of 446.35 g/mol. Its IUPAC name is 6-bromo-N-methyl-2-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-imidazo[4,5-b]pyridin-7-amine.
Molecular Properties
| Compound Name | 6-bromo-N-methyl-2-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-imidazo[4,5-b]pyridin-7-amine |
|---|---|
| PubChem CID | 70689445 |
| Molecular Formula | C20H24BrN5O2 |
| Molecular Weight | 446.35 g/mol |
| Exact Mass | 445.11 |
| IUPAC Name | 6-bromo-N-methyl-2-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-imidazo[4,5-b]pyridin-7-amine |
| SMILES | CNc1c(Br)cnc2nc(-c3ccc(OCCCN4CCOCC4)cc3)[nH]c12 |
| InChI | InChI=1S/C20H24BrN5O2/c1-22-17-16(21)13-23-20-18(17)24-19(25-20)14-3-5-15(6-4-14)28-10-2-7-26-8-11-27-12-9-26/h3-6,13H,2,7-12H2,1H3,(H2,22,23,24,25) |
| InChIKey | WSBFFVQWZREUMG-UHFFFAOYSA-N |
| XLogP | 3.53 |
| TPSA | 75.30 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 446.35 |
| LogP ≤ 5 | 3.53 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70689445 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.